On May 4, 2022, the Food and Drug Administration (FDA) issued warning letters to five companies it asserts are illegally marketing products labeled as containing delta-8 tetrahydrocannabinol (Delta-8 THC) in ways that violate...more
On September 26, 2019, the US Food and Drug Administration (FDA) published six guidance documents clarifying its scope of authority and enforcement discretion policies in light of the 21st Century Cures Act (Cures Act). The...more
10/1/2019
/ 21st Century Cures Act ,
Artificial Intelligence ,
Electronic Medical Records ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Innovative Technology ,
Machine Learning ,
Medical Devices ,
New Guidance ,
Prescription Drugs ,
Regulatory Requirements